Evidence map›Paper›PMID 31873983›Full record

ArticleJournal of clinical hypertension (Greenwich, Conn.)2020

The effects of hypertension and diabetes on new-onset chronic kidney disease: A prospective cohort study.

Miao Wang, Junjuan Li, Yao Li, Siyu Yao, Maoxiang Zhao, Chi Wang, Shouling Wu, Hao Xue

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical hypertension (Greenwich, Conn.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 4 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 4 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Trial
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Miao WangDepartment of Cardiology, Chinese People's Liberation Army General Hospital, Beijing, China.
Junjuan LiDepartment of Nephrology, Kailuan Hospital, Hebei United University, Tangshan, China.
Yao LiDepartment of Cardiology, Chinese People's Liberation Army General Hospital, Beijing, China.
Siyu YaoDepartment of Cardiology, Chinese People's Liberation Army General Hospital, Beijing, China.
Maoxiang ZhaoDepartment of Cardiology, Chinese People's Liberation Army General Hospital, Beijing, China.
Chi WangDepartment of Cardiology, Chinese People's Liberation Army General Hospital, Beijing, China.
Shouling WuDepartment of Cardiology, Kailuan Hospital, Hebei United University, Tangshan, China.
Hao XueDepartment of Cardiology, Chinese People's Liberation Army General Hospital, Beijing, China.ORCID 0000-0001-5915-4811
People's Liberation Army No. 150 Hospital · CNNorth China University of Science and Technology · CNNankai University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study aimed to determine the different status of hypertension and diabetes on the risk of new-onset chronic kidney disease (CKD) events in Kailuan Study. A total of 21 905 individuals were enrolled in the study. The new-onset incidents of CKD, hypertension, and diabetes were collected in the follow-ups. All the individuals were divided into five groups according to baseline and follow-up hypertension and diabetes status: baseline hypertension (BH), baseline hypertension and incidence of diabetes (BHID), baseline diabetes (BD), baseline diabetes and incidence of hypertension (BDIH), and baseline hypertension and diabetes (BHD). The risk of new-onset CKD of the five groups was calculated using the Cox regression analysis. In the median follow-up of 7.05 ± 2.59 years, the prevalence of new-onset CKD in the group of BH, BHID, BD, BDIH, and BHD were 27.1, 43.79, 25.4, 36.6, and 45.1 per 1000 years, respectively. When adjusted possible confounders, the hazard ratios (HRs) and 95% confidence intervals (CIs) of new-onset CKD were 1.50 (95% CI: 1.38-1.63), 1.25(95% CI: 1.07-1.47), and 1.52 (95% CI: 1.35-1.7) in the group of BHID, BDIH, and BHD, respectively, as referred to the BH group (P < .001). No obvious difference was observed in the group of BH and BD for the incidence of new-onset CKD. Sensitivity analysis still showed the similar results among the five groups. The study showed that the effect of simple hypertension or simple diabetes on new-onset CKD was not significantly different, but the incidence of new-onset hypertension or diabetes increased the risk of new-onset CKD. Hypertension and diabetes had a synergistic influence on the risk of new-onset CKD.

Indexed as

Diabetes MellitusHypertensionRenal Insufficiency, ChronicChinaDiabetes ComplicationsHumansIncidenceProspective StudiesRisk Factorschronic kidney diseasediabeteshypertension

Identifiers

PMID31873983
PMCPMC8030069
OpenAlexW2997696654

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.